Literature DB >> 8396389

Effects of cisplatin and ORG.2766 in chick embryonic brain cell cultures.

A Bruinink1, F Birchler.   

Abstract

The neurotoxicity of cisplatin and ORG.2766, both separately and in combination, was investigated using serum-free chick embryonic brain cell cultures. At low cisplatin concentrations glial cells were affected more than nerve cells. The onset of cisplatin toxicity was delayed, the major effects only being seen after the treatment was finished and when no free cisplatin was present in the culture medium. The data further indicate that the area under the graph of free cisplatin concentration in the culture medium against time (AUC) is a measure of cisplatin toxicity. The AUC of free cisplatin in the culture medium which causes a 50% reduction in the expression of glial fibrillary associated protein (GFAP) was similar to blood AUC values in humans known to induce neurotoxic effects in around 80% of patients. ORG.2766 at very high concentrations increased lysosomal activity, as measured by neutral red uptake, and the expression of GFAP. ORG.2766 did not influence the toxicity of cisplatin in culture.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8396389     DOI: 10.1007/bf01973703

Source DB:  PubMed          Journal:  Arch Toxicol        ISSN: 0340-5761            Impact factor:   5.153


  22 in total

1.  Intra-arterial chemotherapy by cisplatin and cytarabine after temporary disruption of the blood-brain barrier for the treatment of malignant gliomas in adults.

Authors:  F Fauchon; J Chiras; M Poisson; M Rose; L Terrier; J Bories; R A Guérin
Journal:  J Neuroradiol       Date:  1986       Impact factor: 3.447

2.  A series of normal stages in the development of the chick embryo.

Authors:  V HAMBURGER; H L HAMILTON
Journal:  J Morphol       Date:  1951-01       Impact factor: 1.804

Review 3.  Toxic effects of cis-dichlorodiammineplatinum(II) in man.

Authors:  D D Von Hoff; R Schilsky; C M Reichert; R L Reddick; M Rozencweig; R C Young; F M Muggia
Journal:  Cancer Treat Rep       Date:  1979 Sep-Oct

4.  alpha-MSH and Org.2766 in peripheral nerve regeneration: different routes of delivery.

Authors:  C E Van der Zee; J H Brakkee; W H Gispen
Journal:  Eur J Pharmacol       Date:  1988-03-15       Impact factor: 4.432

Review 5.  Neurotrophic factors and regeneration in the peripheral nervous system.

Authors:  W A Bijlsma; F G Jennekens; P Schotman; W H Gispen
Journal:  Psychoneuroendocrinology       Date:  1984       Impact factor: 4.905

6.  Immunocytochemical detection of interaction products of cis-diamminedichloroplatinum(II) and cis-diammine(1,1-cyclobutanedicarboxylato)platinum(II) with DNA in rodent tissue sections.

Authors:  P M Terheggen; B G Floot; E Scherer; A C Begg; A M Fichtinger-Schepman; L den Engelse
Journal:  Cancer Res       Date:  1987-12-15       Impact factor: 12.701

7.  Peripheral neuropathy associated with cis-dichlorodiammineplatinum (II) treatment.

Authors:  D Hadley; H W Herr
Journal:  Cancer       Date:  1979-12       Impact factor: 6.860

8.  Cisplatin neuropathy. Clinical, electrophysiologic, morphologic, and toxicologic studies.

Authors:  S W Thompson; L E Davis; M Kornfeld; R D Hilgers; J C Standefer
Journal:  Cancer       Date:  1984-10-01       Impact factor: 6.860

9.  Ontogeny of MAP2 and GFAP antigens in primary cultures of embryonic chick brain. Effect of substratum, oxygen tension, serum and Ara-C.

Authors:  A Bruinink; P Reiser
Journal:  Int J Dev Neurosci       Date:  1991       Impact factor: 2.457

10.  A phase II study of cisplatin therapy in recurrent childhood brain tumors. A report from the Childrens Cancer Study Group.

Authors:  S J Bertolone; E S Baum; W Krivit; G D Hammond
Journal:  J Neurooncol       Date:  1989-05       Impact factor: 4.130

View more
  1 in total

1.  Neurotoxic effects of aluminium on embryonic chick brain cultures.

Authors:  J P Müller; A Bruinink
Journal:  Acta Neuropathol       Date:  1994       Impact factor: 17.088

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.